LOGO
LOGO

Quick Facts

Lamb Weston Q4 Profit Declines

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Lamb Weston Holdings, Inc. (LW), a food processing company, on Wednesday announced that net income decreased in the fourth quarter compared to the previous year.

Shares of Lamb Weston are increasing by around 14% in the pre-market trading.

For the fourth quarter, net income decreased to $119.9 million from $129.6 million in the previous year.

Earnings per share were $0.85 versus $0.89 last year.

Adjusted net income came in at 122.8 million. Adjusted earnings per share were $0.87.

Eight analysts, on average, had expected the company to report $0.64 per share. Analysts' estimates typically exclude special items.

Adjusted EBITDA increased to $284.9 million from $283.4 million in the prior year.

Income from operations decreased to $185.8 million from $212.5 million last year.

Adjusted income from operations increased to $187.9 million from $816.6 million in the previous year.

Net sales were $1.68 billion, up from $1.61 billion in the previous year.

Looking ahead to fiscal 2026, the company expected net sales to range between $6.35 billion and $6.55 billion.

The adjusted EBITDA for the fiscal year 2026 is anticipated to range between $1.000 billion and $1.200 billion.

In the pre-market trading, Lamb Weston is 14.97% higher at $56.49 on the New York Stock Exchange.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

RELATED NEWS
Latest Updates on COVID-19